Excellent result here.
Surely this should be the disorder that Neurotech will formalise its clinical development plan for a provisional TGA application pathway given that ODD/IND are the preferred pathways for PANDAS/PANS and Retts.
Remarkably off the radar this stock, by my thinking.
Ann: Significant improvement in Autism patients at 12 weeks, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $57.93M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.4¢ | $27.17K | 489.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 112542 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 423746 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |